CBU
IDYA icon

CIBC Bancorp USA’s IDEAYA Biosciences IDYA Stock Holding History

CIBC Bancorp USA’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$233K Buy
+8,561
New +$207K ﹤0.01% 1198

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CIBC Bancorp USA's IDYA Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in IDEAYA Biosciences (IDYA) in Q3 2025: 8,561 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1198 among its holdings.

224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • CIBC Bancorp USA held 8,561 shares of IDEAYA Biosciences worth $233K as of Q3 2025.
  • IDEAYA Biosciences was a new CIBC Bancorp USA position in Q3 2025.
  • IDEAYA Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1198 holding.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.